JANX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own JANX shares is 242, representing 86.25% of the company's common stock.

EXCHANGE TRADED CONCEPTS, LLC, in the last quarter, reduced its stake in JANX by -46.89% restricting it's holding to 7.54 thousand shares of worth nearly $284.03K. BVF INC/IL also lessened -36.25% of the JANX shares from its portfolio, reducing its holding to 2.92 million shares of worth $109.93M. NORTHERN TRUST CORP also shunned JANX shares holding by -0.99% last quarter which brought its holding to 201.98 thousand shares worth $7.60M.

As per its latest 13F filing, FMR LLC increased its stake in JANX by 65.89% in the last quarter. The institutional holder raised its holding to 7.75 million shares having worth more than $291.75M. INVESCO LTD. also added 100% more shares of JANX to its portfolio, raising its holding to 7.81 thousand shares of worth $293.93K. BAILARD, INC. also increased its JANX shares holding by 100% which brought its holding to 7.4 thousand shares worth $278.61M.

The insider with the most stakes in JANX is RA CAPITAL MANAGEMENT, L.P. , at the company. Additionally, JANX stock is highly held by 10 percent owner Bregua Corp and Acting Chief Financial Officer Reardon Tighe among others.

Company executives, directors, and other insiders own 7.22% percent of Janux Therapeutics, Inc.'s stock. Within the last six months, there have been 20 transaction(s) in which JANX insiders have sold stock, totaling 307.19K shares. Insiders that have sold shares include CAMPBELL DAVID ALAN, MEYER ANDREW HOLLMAN, and AVALON VENTURES XI, L.P..

There have been 1 transaction(s) during the past 6-months in which Janux Therapeutics, Inc. insiders have bought stock, totalling 1200000 shares

Around 13.95M Janux Therapeutics, Inc. shares are held by insiders, which represents about 7.22% of JANX stock.

JANX , RA CAPITAL MANAGEMENT, L.P. holds the largest portfolio of the company's shares. JANX shares owned by RA total nearly 9.32 million.

FMR LLC is the largest institutional owner in JANX which holds 7.75 million shares worth $291.75M or 17.6% of the total JANX shares outstanding followed by INVESCO LTD. with ownership of 7.81 thousand shares representing 0.02% of the JANX ownership. EXCHANGE TRADED CONCEPTS, LLC is the third largest stakeholder with 7.54 thousand shares or 0.02% of the ownership worth more than $284.03K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the JANX is concerned, it is a stock which is optionable.

Number of JANX shares short is 7.68M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 58.63M shares of JANX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, JANX has 38.00M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for JANX is 4.79.